Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ABI-007 status in breast cancer updated

Feb. 19, 2002

Sugen prepares inhibitors of protein kinases with potential in cancer, etc.

Feb. 19, 2002

MDA-7 expression lost with progression of melanoma; data support use of INGN-241 in melanoma

Feb. 19, 2002

Microbial metabolite pipalamycin induces apoptosis in cancer cells

Feb. 19, 2002

Replikins: new targets for the detection and treatment of cancer

Feb. 19, 2002

Maxim reports advances in its proapoptotic drug discovery program

Feb. 19, 2002

Merck claims preparation of macrocyclic compounds for treatment of cancer, etc.

Feb. 18, 2002

Phytomedics and Eisai collaborate to discover cancer therapeutics

Feb. 18, 2002

Tripeptide prodrugs of therapeutic agents with improved toxicity profile prepared at Corixa

Feb. 15, 2002

Patient enrollment begins for ALVAC-CEA/B7.1 study in colorectal cancer

Feb. 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...